IRADIMED CORPORATION Cash and Restricted Cash
IRADIMED CORPORATION (IRMD) had Cash and Restricted Cash of $59.08 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-31
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.08M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.37M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $51.16M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.53M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $59.08M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $56.37M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $51.16M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $56.53M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $53.00M 10-Q · filed 2026-07-31 | $53.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $50.33M 10-Q · filed 2026-05-01 | $50.33M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $52.23M 10-Q · filed 2026-07-31 | $52.23M 10-K · filed 2025-03-06 |
| 2024-09-30 | $51.72M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $48.54M 10-Q · filed 2025-08-01 | |
| 2024-03-31 | $45.13M 10-Q · filed 2025-05-05 | $45.13M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $49.76M 10-K · filed 2026-03-06 | $49.76M 10-K · filed 2024-03-01 |
| 2023-09-30 | $46.75M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $45.82M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | $42.78M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $57.96M 10-K/A · filed 2025-09-03 | |
| 2022-09-30 | $55.59M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $52.16M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $50.45M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $62.00M 10-K · filed 2024-03-01 | |
| 2021-09-30 | $58.37M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $55.16M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $50.80M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $50.07M 10-K · filed 2023-03-02 | |
| 2020-09-30 | $47.55M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $45.46M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $44.64M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $43.48M 10-K · filed 2022-03-04 | |
| 2019-09-30 | $38.64M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $32.42M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $29.68M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $28.03M 10-K · filed 2022-03-04 | |
| 2018-09-30 | $23.70M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $21.33M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $20.09M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $18.21M 10-K · filed 2021-03-05 | |
| 2017-09-30 | $18.41M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $16.80M 10-Q · filed 2018-08-08 | |
| 2016-12-31 | $17.71M 10-K · filed 2020-03-06 | |
| 2015-12-31 | $19.37M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |